3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
7
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Refractory or Relapsed Solid Tumors
1
Prostatic Neoplasms, Castration-Resistant
1
Non-metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-resistant Prostate Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Biochemically Recurrent Prostate Cancer
1
Adenocarcinoma
1
Interventions
ruxolitinib
3
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Cyclosporine
2
umbralisib
1
itacitinib
1
iadademstat
1
fludarabine
1
decitabine and cedazuridine drug combination
1
Specimen Handling
1
Sirolimus
1
Panobinostat
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
INCB039110
1
Hyperbaric Oxygenation
1
Etoposide
1
CPI-0610
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Primary Myelofibrosis
×
darolutamide
×
30 days
×
Clear all
No trials found.